Healthtech Startups

Nomic offers an end-to-end protein profiling service built on its nELISA technology, quantifying up to 1000 informative proteins with absolute quantification for research studies. It targets researchers doing proteomics work, aiming for high-throughput, low-cost profiling in the biotech and life sciences market.

5 investors

Noninvasix develops a patented optoacoustic platform that non-invasively and continuously measures central venous oxygen saturation to help ICU clinicians diagnose and monitor tissue hypoxia in sepsis and septic shock patients in real time. The technology is aimed at critical care settings, with planned applications in fetal monitoring, neonatal care, traumatic brain injury, and blood loss.

5 investors

Normunity develops biologic anti-cancer therapies that act at the interface of the immune system and tumors, targeting mechanisms tumors use to evade immune surveillance. The company builds its drug discovery pipeline through a partnership with the Lieping Chen lab at Yale School of Medicine, focusing on solid tumors.

5 investors

Nostos Genomics develops genetic testing interpretation tools to improve the accuracy, speed, and accessibility of variant analysis for patients with rare and genetic diseases. The company addresses the diagnostic bottleneck in genetic sequencing by providing better information interpretation for patients and healthcare systems.

5 investors

Nuvig Therapeutics develops immune-modulating medicines for autoimmune diseases by harnessing endogenous regulatory mechanisms to resolve immune dysregulation. The company targets patients with chronic inflammatory and autoimmune conditions.

5 investors

Nym automates the medical coding process for US healthcare providers by using AI to interpret clinical language and power revenue cycle management. The company's autonomous coding engine processes millions of patient encounters annually across over 400 healthcare facilities.

5 investors

Olio Labs develops drug combination therapies using machine learning to identify treatments that target multiple interacting proteins simultaneously, with initial candidates focused on obesity treatment. The company aims to create pharmaceutical solutions that achieve greater efficacy and lower side effect profiles than existing single-target medications.

5 investors

On Target Laboratories is a company of scientists and researchers focused on cancer surgery, developing products to support surgical oncology. It operates in the biotech and medtech space.

5 investors

OncoLens is an AI-enabled digital health platform that extracts and analyzes structured and unstructured clinical, pathology, and lab data from EMRs to support oncology workflows such as tumor board operations, clinical trial matching, registry reporting, and real-world evidence generation. It serves cancer centers, oncology providers, and life science/pharma partners through its research network connecting them for trials and data projects.

5 investors

Oncoustics develops ultrasound-based artificial intelligence and machine learning solutions for cancer detection and liver disease characterization, serving clinical researchers and healthcare providers. The company operates research collaborations with Stanford University, University of Toronto, and international health institutes across Toronto, Cairo, and Palo Alto.

5 investors

OncoveryCare develops survivorship care solutions for cancer survivors, addressing the medical and quality-of-life needs of people living after cancer treatment.

5 investors

Opencare operates a curated network of vetted dentists across North America that helps patients find and access quality dental care. The platform connects patients with top-rated dental practices committed to oral wellness.

5 investors

ORIC Pharmaceuticals is a clinical-stage oncology company developing therapies aimed at overcoming cancer treatment resistance, including innate, acquired, and bypass resistance. Its pipeline includes rinzimetostat (ORIC-944) in Phase 1b for prostate cancer and enozertinib (ORIC-114) in Phase 1b for non-small cell lung cancer with EGFR mutations.

5 investors

Orum is a global biopharmaceutical company developing cancer therapies that combine protein degraders with antibodies. It focuses on Degrader Antibody Conjugate (DAC) technology to research and develop new therapeutics.

5 investors

Overture develops automation and technology to improve fertility treatment, aiming to lower costs and increase success rates. It targets the fertility care market and the people undergoing such treatment.

5 investors

Oviva offers personalised dietary advice paired with a digital app to help people change eating habits and manage or prevent illness. It serves individuals looking to improve their health through targeted dietary changes.

5 investors

Pacagen develops allergen-neutralizing sprays using proprietary WhiskerBlock™ and EnviroBlock™ technologies that target pet and dust mite allergens at the molecular level. The company serves allergy sufferers seeking an alternative to traditional antihistamines and medications.

5 investors

Paloma Health offers thyroid care products including Daily Thyroid Care, an iodine-free thyroid-support multivitamin blending vitamins, minerals, and botanicals for people managing thyroid conditions such as hypothyroidism and Hashimoto's. The company sells thyroid supplements direct to consumers as part of its thyroid health offering.

5 investors

PanTera develops actinium-225, a therapeutic radioisotope used in precision cancer treatment through radiotheranostics, serving oncology patients and pharmaceutical companies globally. The company operates a production facility in Belgium producing high-purity actinium-225 as an active pharmaceutical ingredient for personalized nuclear medicine treatments.

5 investors

Parallel provides evidence-based services and assessment tools for schools and education providers to support students with learning differences. The platform connects educators and specialists to help diagnose and address conditions like dyslexia and ADHD.

5 investors

5 investors

Enterprise SaaS platform and licensed insurance agency providing individual life and disability insurance through a multi-carrier marketplace.

5 investors

Pendulum is a probiotic and prebiotic supplement company that develops clinically-tested products targeting gut health, metabolic function, and glucose control, including proprietary strains like live Akkermansia.

5 investors

Perceptive applies AI and robotics technology to dental practice, helping dentists increase patient capacity. The company serves dental service organizations and practices seeking to modernize clinical workflows.

5 investors